The schizophrenia is a psychiatric disorder whose etiology is still not known, experts believe there is together a of environmental and genetic factors that contribute to the development of this disease.
Increasingly 's start to understand the mechanisms and find more specific and effective treatments, and obtained a positive result appears for now on laboratory rats, administering an anticancer drug called MS-275, within the framework of a study conducted by King's College London.
In patients with schizophrenia there is a deficit p35 enzyme, as explained by Peter Giese Research Coordinator. The exact function of this enzyme underliesactivation of protein Cdk5 important for brain development. Therefore a sufficient amount of p35 not does not allow that this chain is properly and, therefore brain , does not develop as it should.
It seems that the molecule MS-275 in mice has improved the signs of schizophrenia because acts same along the via biochemical enzyme p35. According to Peter Giese results i obtained from the study, published in the journal Brain: "Encourages the exploration future of these types of drugs in the treatment of cognitive disorders in schizophrenia".
Increasingly 's start to understand the mechanisms and find more specific and effective treatments, and obtained a positive result appears for now on laboratory rats, administering an anticancer drug called MS-275, within the framework of a study conducted by King's College London.
In patients with schizophrenia there is a deficit p35 enzyme, as explained by Peter Giese Research Coordinator. The exact function of this enzyme underliesactivation of protein Cdk5 important for brain development. Therefore a sufficient amount of p35 not does not allow that this chain is properly and, therefore brain , does not develop as it should.
It seems that the molecule MS-275 in mice has improved the signs of schizophrenia because acts same along the via biochemical enzyme p35. According to Peter Giese results i obtained from the study, published in the journal Brain: "Encourages the exploration future of these types of drugs in the treatment of cognitive disorders in schizophrenia".
0 comments:
Post a Comment